No Data
No Data
Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
Piper Sandler Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
10 Health Care Stocks With Whale Alerts In Today's Session
Why Viking Therapeutics Stock Was Victorious This Week
Viking Therapeutics Call Volume Above Normal and Directionally Bullish
Where Will Viking Therapeutics Be in 3 Years?